Free Trial

NLS Pharmaceutics (NLSP) Institutional Ownership

NLS Pharmaceutics logo
$3.60
-0.03 (-0.83%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for NLS Pharmaceutics (NASDAQ:NLSP)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$30.15K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$139.68K
Get NLSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling NLS Pharmaceutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NLSP Institutional Buying and Selling by Quarter

NLS Pharmaceutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024Armistice Capital LLC2,311,000$501K0.0%+6.4%19.618%
11/15/2023Affinity Asset Advisors LLC200,455$140K0.0%-49.9%0.000%
8/21/2023Affinity Asset Advisors LLC400,000$440K0.2%+16.2%0.000%
5/15/2023Affinity Asset Advisors LLC344,089$520K0.2%N/A2.921%
11/16/2021Two Sigma Securities LLC10,140$25K0.0%N/A0.086%
8/13/2021Renaissance Technologies LLC41,997$132K0.0%N/A0.357%
5/20/2021Axiom Investment Management LLC68,000$273K0.1%N/A0.577%
5/18/2021Millennium Management LLC33,213$134K0.0%N/A0.282%
(Data available from 1/1/2016 forward)

NLSP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NLSP shares?

During the previous two years, the following institutional investors and hedge funds held shares of NLS Pharmaceutics shares: Armistice Capital LLC ($501K), Affinity Asset Advisors LLC ($140K).Learn more on NLSP's institutional investors.

Which institutional investors have been buying NLS Pharmaceutics stock?

The following institutional investors have purchased NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($400K), and Armistice Capital LLC ($139K).

How much institutional buying is happening at NLS Pharmaceutics?

Institutional investors have bought a total of 539,000 shares in the last 24 months. This purchase volume represents approximately $614.67K in transactions.

Which NLS Pharmaceutics major shareholders have been selling company stock?

The following institutional investors have sold NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($199.55K).

How much institutional selling is happening at NLS Pharmaceutics?

Institutional investors have sold a total of 199,545 shares in the last 24 months. This volume of shares sold represents approximately $139.68K in transactions.



This page (NASDAQ:NLSP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners